chloroquine has been researched along with Basal Ganglia Diseases in 8 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chloroquine is considered essentially nontoxic when used for the chemosuppression of malaria, but gastrointestinal upsets, headache, blurring of vision, pruritus, and uritcaria may occur during chloroquine therapy." | 7.66 | Extrapyramidal syndrome following chloroquine therapy. ( Singh, M; Singhi, P; Singhi, S, 1979) |
| "Chloroquine is considered essentially nontoxic when used for the chemosuppression of malaria, but gastrointestinal upsets, headache, blurring of vision, pruritus, and uritcaria may occur during chloroquine therapy." | 3.66 | Extrapyramidal syndrome following chloroquine therapy. ( Singh, M; Singhi, P; Singhi, S, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ings, RM | 1 |
| Khabya, BL | 1 |
| Singhi, S | 2 |
| Singhi, P | 2 |
| Singh, M | 2 |
| Khilnani, G | 1 |
| Swaroop, AK | 1 |
| Goyal, RK | 2 |
| Mathur, RN | 1 |
| Mayer, K | 1 |
| Chaudhary, HR | 1 |
| Meena, SR | 1 |
| Jani, D | 1 |
| Tiwari, U | 1 |
| Achumba, JI | 1 |
| Ette, EI | 1 |
| Thomas, WO | 1 |
| Essien, EE | 1 |
1 review available for chloroquine and Basal Ganglia Diseases
| Article | Year |
|---|---|
The melanin binding of drugs and its implications.
Topics: Animals; Basal Ganglia Diseases; Chloroquine; Ear, Inner; Eye; Female; Fetus; Humans; Melanins; Phar | 1984 |
7 other studies available for chloroquine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Acute extra pyramidal syndromes due to phenothiazines given with chloroquin--possible drug interaction.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chloroquine; Drug Interactions; Humans; Phenothiazines | 1976 |
Extrapyramidal syndrome following chloroquine therapy.
Topics: Basal Ganglia Diseases; Child; Child, Preschool; Chloroquine; Female; Humans; Malaria; Male; Syndrom | 1979 |
Extra pyramidal reactions due to chloroquin and phenothiazines.
Topics: Adolescent; Adult; Basal Ganglia; Basal Ganglia Diseases; Child; Child, Preschool; Chloroquine; Fema | 1979 |
Chloroquine-induced involuntary movements.
Topics: Basal Ganglia Diseases; Child; Child, Preschool; Chloroquine; Humans; Movement Disorders | 1977 |
[Neurogenic symptoms for the early diagnosis of adverse drug effects].
Topics: Anti-Bacterial Agents; Anticoagulants; Basal Ganglia Diseases; Chloroquine; Cortisone; Depression; D | 1976 |
Extrapyramidal syndrome in cerebral malaria.
Topics: Animals; Basal Ganglia Diseases; Chloroquine; Humans; Malaria, Cerebral; Malaria, Vivax; Male; Middl | 1992 |
Chloroquine-induced acute dystonic reactions in the presence of metronidazole.
Topics: Adult; Basal Ganglia Diseases; Chloroquine; Diazepam; Drug Interactions; Dystonia; Female; Humans; M | 1988 |